CETROTIDE 0.25 mg, powder and solvent for solution for injection bottle, 1 ml
Active ingredients: Cetrorelix monoacetate, Cetrorelix
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for solution for injectionbottle, 1 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CETROTIDE 0,25 mg, poudre et solvant pour solution injectable
- Pharmaceutical form
- poudre et solvant pour solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 1 flacon(s) en verre - 1 seringue(s) préremplie(s) en verre de 1 ml avec aiguille(s) avec tampon(s) alcoolisé(s)
- Marketing authorisation holder
- MERCK EUROPE (PAYS-BAS)
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Jun 2000
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60650426CIP73517790CIP133400935177902Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CÉTRORÉLIX BASEpoudre | 0,25 mg · un flacon | FT |
| ACÉTATE DE CÉTRORÉLIXpoudre | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.